CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Asensus Surgical, Inc. - ASXC CFD

0.2714
2.53%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0116
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026207 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026207%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003985 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003985%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Asensus Surgical Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 0.2647
Open* 0.2912
1-Year Change* -28.29%
Day's Range* 0.2692 - 0.2912
52 wk Range 0.20-1.18
Average Volume (10 days) 2.02M
Average Volume (3 months) 50.29M
Market Cap 62.11M
P/E Ratio -100.00K
Shares Outstanding 264.32M
Revenue 5.61M
EPS -0.33
Dividend (Yield %) N/A
Beta 1.48
Next Earnings Date Feb 29, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Nov 27, 2023 0.2647 0.0099 3.89% 0.2548 0.2774 0.2494
Nov 24, 2023 0.2582 0.0236 10.06% 0.2346 0.2639 0.2283
Nov 22, 2023 0.2345 0.0012 0.51% 0.2333 0.2418 0.2297
Nov 21, 2023 0.2315 0.0053 2.34% 0.2262 0.2433 0.2212
Nov 20, 2023 0.2261 -0.0022 -0.96% 0.2283 0.2295 0.2215
Nov 17, 2023 0.2318 0.0085 3.81% 0.2233 0.2369 0.2168
Nov 16, 2023 0.2170 -0.0022 -1.00% 0.2192 0.2214 0.2124
Nov 15, 2023 0.2171 -0.0079 -3.51% 0.2250 0.2250 0.2090
Nov 14, 2023 0.2297 0.0022 0.97% 0.2275 0.2411 0.2092
Nov 13, 2023 0.2067 0.0006 0.29% 0.2061 0.2144 0.2044
Nov 10, 2023 0.2092 -0.0092 -4.21% 0.2184 0.2236 0.2068
Nov 9, 2023 0.2174 -0.0109 -4.77% 0.2283 0.2332 0.2128
Nov 8, 2023 0.2294 0.0010 0.44% 0.2284 0.2333 0.2256
Nov 7, 2023 0.2292 -0.0091 -3.82% 0.2383 0.2383 0.2283
Nov 6, 2023 0.2312 0.0029 1.27% 0.2283 0.2408 0.2262
Nov 3, 2023 0.2194 0.0035 1.62% 0.2159 0.2299 0.2090
Nov 2, 2023 0.2106 0.0011 0.53% 0.2095 0.2193 0.2042
Nov 1, 2023 0.2100 -0.0149 -6.63% 0.2249 0.2258 0.2024
Oct 31, 2023 0.2219 0.0185 9.10% 0.2034 0.2321 0.1993
Oct 30, 2023 0.2020 -0.0099 -4.67% 0.2119 0.2153 0.2010

Asensus Surgical, Inc. Events

Time (UTC) Country Event
Thursday, February 29, 2024

Time (UTC)

21:00

Country

US

Event

Q4 2023 Asensus Surgical Inc Earnings Release
Q4 2023 Asensus Surgical Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 7.087 8.232 3.175 8.531 24.102
Revenue 7.087 8.232 3.175 8.531 24.102
Cost of Revenue, Total 10.872 11.096 5.166 20.731 16.171
Gross Profit -3.785 -2.864 -1.991 -12.2 7.931
Total Operating Expense 82.766 70.004 63.564 163.106 73.254
Selling/General/Admin. Expenses, Total 34.928 32.718 27.201 46.772 39.59
Research & Development 28.942 19.348 16.621 22.468 21.823
Depreciation / Amortization 7.708 11.254 10.801 10.301 10.868
Unusual Expense (Income) 1.431 -2.847 0.851 72.387 -14.187
Other Operating Expenses, Total -1.115 -1.565 2.924 -9.553 -1.011
Operating Income -75.679 -61.772 -60.389 -154.575 -49.152
Interest Income (Expense), Net Non-Operating 0.731 -1.761 -0.32 -1.783 -17.128
Other, Net -0.295 1.296 -0.119 -0.967 1.126
Net Income Before Taxes -75.243 -62.237 -60.828 -157.325 -65.154
Net Income After Taxes -75.561 -62.462 -59.312 -154.201 -61.777
Net Income Before Extra. Items -75.561 -62.462 -59.312 -154.201 -61.777
Net Income -75.561 -62.462 -59.312 -154.201 -61.777
Income Available to Common Excl. Extra. Items -75.561 -62.462 -60.023 -154.201 -61.777
Income Available to Common Incl. Extra. Items -75.561 -62.462 -60.023 -154.201 -61.777
Diluted Net Income -75.561 -62.462 -60.023 -154.201 -61.777
Diluted Weighted Average Shares 236.492 226.96 70.809 17.737 15.9384
Diluted EPS Excluding Extraordinary Items -0.31951 -0.27521 -0.84767 -8.69375 -3.87599
Diluted Normalized EPS -0.31557 -0.28337 -0.83986 -5.88489 -4.45456
Total Extraordinary Items
Total Adjustments to Net Income 0 -0.711
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 1.081 0.976 2.464 2.563 0.994
Revenue 1.081 0.976 2.464 2.563 0.994
Cost of Revenue, Total 3.074 2.947 2.298 4.404 2.347
Gross Profit -1.993 -1.971 0.166 -1.841 -1.353
Total Operating Expense 21.944 23.324 20.591 21.595 20.561
Selling/General/Admin. Expenses, Total 9.573 10.021 8.614 8.468 8.594
Research & Development 8.98 10.139 8.52 6.741 7.253
Depreciation / Amortization 0.114 0.112 0.107 2.398 2.533
Unusual Expense (Income) 0 0.999 0 0.432
Other Operating Expenses, Total 0.203 0.105 0.053 -0.416 -0.598
Operating Income -20.863 -22.348 -18.127 -19.032 -19.567
Interest Income (Expense), Net Non-Operating 0.431 0.439 0.365 0.192 0.119
Other, Net -0.242 -0.218 -0.034 -0.029 -0.086
Net Income Before Taxes -20.674 -22.127 -17.796 -18.869 -19.534
Net Income After Taxes -20.662 -22.218 -17.89 -18.924 -19.619
Net Income Before Extra. Items -20.662 -22.218 -17.89 -18.924 -19.619
Net Income -20.662 -22.218 -17.89 -18.924 -19.619
Total Adjustments to Net Income
Income Available to Common Excl. Extra. Items -20.662 -22.218 -17.89 -18.924 -19.619
Income Available to Common Incl. Extra. Items -20.662 -22.218 -17.89 -18.924 -19.619
Diluted Net Income -20.662 -22.218 -17.89 -18.924 -19.619
Diluted Weighted Average Shares 239.57 238.28 236.849 236.713 236.505
Diluted EPS Excluding Extraordinary Items -0.08625 -0.09324 -0.07553 -0.07994 -0.08295
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.08625 -0.09324 -0.07279 -0.07994 -0.08177
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 86.873 113.297 34.013 27.955 101.583
Cash and Short Term Investments 70.524 98.391 16.363 9.598 72.851
Cash & Equivalents 6.329 18.129 16.363 9.598 21.061
Total Receivables, Net 2.81 2.06 3.985 3.336 8.595
Accounts Receivable - Trade, Net 2.256 0.749 1.115 0.62 8.56
Total Inventory 8.284 8.634 10.034 10.653 10.941
Prepaid Expenses 3.584 3.255 3.631 4.368 9.196
Total Assets 116.053 186.473 78.258 74.779 239.307
Property/Plant/Equipment, Total - Net 14.492 16.319 11.542 7.006 6.337
Property/Plant/Equipment, Total - Gross 27.172 26.008 25.802 17.974 17.499
Accumulated Depreciation, Total -12.68 -9.689 -14.26 -10.968 -11.162
Goodwill, Net 0 80.131
Intangibles, Net 1.576 9.892 22.267 31.066 50.463
Note Receivable - Long Term
Other Long Term Assets, Total 9.247 9.53 10.436 8.752 0.793
Total Current Liabilities 10.414 9.85 10.283 13.023 21.819
Accounts Payable 3.348 3.448 1.965 3.579 4.433
Accrued Expenses 6.601 5.859 6.301 8.553 9.228
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 1.228 0
Other Current Liabilities, Total 0.465 0.543 0.789 0.891 8.158
Total Liabilities 16.408 17.227 16.689 19.244 70.786
Total Long Term Debt 0 0 1.587 0 28.937
Long Term Debt 0 1.587 0 28.937
Deferred Income Tax 0 1.392 4.72
Other Liabilities, Total 5.994 7.377 4.819 4.829 15.31
Total Equity 99.645 169.246 61.569 55.535 168.521
Common Stock 0.237 0.235 0.116 0.021 0.216
Additional Paid-In Capital 962.731 954.649 781.397 720.484 676.373
Retained Earnings (Accumulated Deficit) -860.935 -785.374 -722.912 -663.6 -509.406
Treasury Stock - Common
Other Equity, Total -2.388 -0.264 2.968 -1.37 1.338
Total Liabilities & Shareholders’ Equity 116.053 186.473 78.258 74.779 239.307
Total Common Shares Outstanding 236.895 235.219 116.231 20.6913 16.6413
Short Term Investments 64.195 80.262 0 51.79
Redeemable Preferred Stock 0 0 0
Total Preferred Shares Outstanding 0
Other Current Assets, Total 1.671 0.957
Long Term Investments 3.865 37.435
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 45.932 54.91 71.556 86.873 103.53
Cash and Short Term Investments 33.089 39.972 56.434 70.524 86.351
Cash & Equivalents 21.669 7.675 18.737 6.329 13.87
Total Receivables, Net 0.662 1.214 1.212 2.81 3.397
Accounts Receivable - Trade, Net 0.662 0.66 0.658 2.256 2.25
Total Inventory 6.683 9.083 8.844 8.284 9.035
Other Current Assets, Total 1.324 1.492 1.74 1.671 1.034
Total Assets 70.727 78.371 96.523 116.053 128.653
Property/Plant/Equipment, Total - Net 14.241 13.703 13.741 14.492 13.944
Intangibles, Net 1.278 1.411 1.506 1.576 1.529
Other Long Term Assets, Total 9.276 8.347 8.762 9.247 7.713
Total Current Liabilities 12.123 10.647 10.877 10.414 9.844
Accounts Payable 4.526 4.281 4.972 3.348 3.637
Accrued Expenses 7.141 5.99 5.449 6.601 5.85
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases
Other Current Liabilities, Total 0.456 0.376 0.456 0.465 0.357
Total Liabilities 23.474 16.868 16.806 16.408 15.677
Total Long Term Debt 0 0 0 0 0
Long Term Debt
Other Liabilities, Total 11.351 6.221 5.929 5.994 5.833
Total Equity 47.253 61.503 79.717 99.645 112.976
Redeemable Preferred Stock 0 0 0 0
Common Stock 0.264 0.24 0.239 0.237 0.237
Additional Paid-In Capital 970.952 966.335 964.162 962.731 960.676
Retained Earnings (Accumulated Deficit) -922.133 -903.815 -883.153 -860.935 -843.045
Other Equity, Total -1.83 -1.257 -1.531 -2.388 -4.892
Total Liabilities & Shareholders’ Equity 70.727 78.371 96.523 116.053 128.653
Total Common Shares Outstanding 264.111 239.97 239.342 236.895 236.783
Total Preferred Shares Outstanding
Short Term Investments 11.42 32.297 37.697 64.195 72.481
Prepaid Expenses 4.174 3.149 3.326 3.584 3.713
Long Term Investments 0 0 0.958 3.865 1.937
Property/Plant/Equipment, Total - Gross 27.172
Accumulated Depreciation, Total -12.68
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -75.561 -62.462 -59.312 -154.201 -61.777
Cash From Operating Activities -58.937 -40.659 -46.675 -73.484 -48.493
Cash From Operating Activities 3.368 2.857 2.898 2.166 2.42
Amortization 7.708 11.254 10.801 10.301 10.868
Deferred Taxes 0.318 0.225 -1.516 -3.224 -3.377
Non-Cash Items 10.185 6.24 11.171 76.825 9.288
Cash Interest Paid 0 0 2.187 1.73
Changes in Working Capital -4.955 1.227 -10.717 -5.351 -5.915
Cash From Investing Activities 47.537 -119.668 -0.003 67.645 -53.481
Capital Expenditures -1.279 -1.368 -0.003 -0.437 -0.77
Cash From Financing Activities -0.332 161.705 53.37 -5.609 26.452
Financing Cash Flow Items -0.35 -1.063 -0.11 -0.499 -2.432
Issuance (Retirement) of Stock, Net 0.018 162.768 50.665 26.315 15.682
Issuance (Retirement) of Debt, Net 0 2.815 -31.425 13.202
Foreign Exchange Effects -0.081 0.376 0.27 0.364 -0.433
Net Change in Cash -11.813 1.754 6.962 -11.084 -75.955
Other Investing Cash Flow Items, Total 48.816 -118.3 0 68.082 -52.711
Cash Taxes Paid -0.165 -0.17
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -22.218 -75.561 -57.671 -38.747 -19.128
Cash From Operating Activities -17.248 -58.937 -44.884 -30.23 -15.943
Cash From Operating Activities 0.813 3.368 2.481 1.72 0.869
Amortization 0.112 7.708 7.601 5.203 2.67
Deferred Taxes 0.091 0.318 0.224 0.169 0.084
Non-Cash Items 1.558 10.185 6.837 3.991 2.303
Changes in Working Capital 2.396 -4.955 -4.356 -2.566 -2.741
Cash From Investing Activities 29.737 47.537 41.21 23.173 23.045
Capital Expenditures -0.064 -1.279 -0.904 -0.443 -0.246
Cash From Financing Activities -0.483 -0.332 -0.332 -0.331 -0.336
Financing Cash Flow Items -0.488 -0.35 -0.35 -0.349 -0.348
Issuance (Retirement) of Stock, Net 0.005 0.018 0.018 0.018 0.012
Foreign Exchange Effects 0.403 -0.081 -0.3 0.239 -0.045
Net Change in Cash 12.409 -11.813 -4.306 -7.149 6.721
Issuance (Retirement) of Debt, Net
Other Investing Cash Flow Items, Total 29.801 48.816 42.114 23.616 23.291
Cash Interest Paid
Cash Taxes Paid -0.19 -0.165 0.079 0.065 -0.029
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 4.3177 11393457 -43403 2023-06-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.3983 3689677 44503 2023-06-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.7989 2108122 -159259 2023-06-30 LOW
Masters Capital Management, L.L.C. Hedge Fund 0.7579 2000000 157000 2023-06-30 MED
Biffi (Andrea) Individual Investor 0.7484 1974823 1482008 2023-04-14 HIGH
Millennium Management LLC Hedge Fund 0.6521 1720676 -203224 2023-06-30 HIGH
Fernando (Anthony C J) Individual Investor 0.5641 1488393 0 2023-04-14 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.3611 952929 -4200 2023-06-30 LOW
GSA Capital Partners LLP Hedge Fund 0.3415 901208 151408 2023-06-30 HIGH
Milne David Bruce Individual Investor 0.2349 619884 0 2023-04-14 LOW
UBS Financial Services, Inc. Investment Advisor 0.2231 588733 51763 2023-06-30 LOW
SV Health Investors, LLC Venture Capital 0.1933 510142 0 2022-09-30 LOW
AlphaCentric Advisors LLC. Investment Advisor 0.1895 500000 0 2023-06-30 HIGH
Pacific View Asset Management, LLC Investment Advisor/Hedge Fund 0.1895 500000 0 2023-06-30 MED
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.166 438092 -1490 2023-06-30 LOW
DWS Investment Management Americas, Inc. Investment Advisor/Hedge Fund 0.1094 288600 0 2023-06-30 LOW
Rampertab (Shameze) Individual Investor 0.0939 247863 9691 2023-07-01 LOW
Pfenniger (Richard C Jr) Individual Investor 0.0718 189417 45000 2023-06-06 LOW
T. Rowe Price International Ltd Investment Advisor/Hedge Fund 0.0703 185500 0 2023-06-30 LOW
T. Rowe Price Associates, Inc. Investment Advisor 0.0703 185500 0 2023-09-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Asensus Surgical, Inc. Company profile

Asensus Surgical (ASXC) is a medical device company that engages in digitising the interface between the surgeon and the patient to improve minimally invasive surgery (MIS). 

Founded in 2006, Asensus is headquartered in Durham, North Carolina. It pioneers a new era of performance-guided surgery, using advanced capabilities, like machine vision, augmented intelligence, connectivity and robotics in laparoscopy. 

Asensus has built the foundation of Digital Laparoscopy with the help of its Senhance Surgical System powered by the Intelligent Surgical Unit (ISU) to address clinical, cognitive and economic shortcomings in surgery.

The Senhance Surgical System is a multi-port robotic system that provides enhanced control with surgeon eye-tracking camera control & 3D (three dimensional) HD (high definition) vision and enhances precision through tremor filtrations and robotic stabilisation. Additionally, surgeons can have enhanced focus during surgery through Asensus’s optimised ergonomics and the sense of touch (haptics). 

The surgical device that consists of a robotic instrument and a camera for laparoscopic procedures is considered to be the smallest instrument offered in robotics, leading to smaller incisions than traditional robotic surgery. Asensus’ Senhance ultrasonic system is an advanced energy device to deliver controlled energy to ligate and divide tissue.

Asensus Surgical previously developed the SPIDER device and the SurgiBot System. It changed its name from TransEnterix in February 2021. The company went public as TransEnterix in May 2014. It trades on the NYSE American under the ticker ‘ASXC’.

Industry: Medical Equipment, Supplies & Distribution (NEC)

1 Tw Alexander Drive
Suite 160
DURHAM
NORTH CAROLINA 27703
US

Income Statement

  • Annual
  • Quarterly

News

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023
GBP

UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

10:48, 21 November 2023

Gold Rises as Traders price-in Fed Rate Cuts

Gold prices have declined despite a drop in Treasury yields and a weaker US Dollar. We look at the key drivers and technical levels for the gold price.

13:17, 20 November 2023
Gold bars

XAU/USD Latest: Gold advances as weaker data weighs on US yields

Gold moves higher as softer economic data weighs on US yields and the dollar

13:43, 17 November 2023

People also watch

Gold

2,041.46 Price
+1.330% 1D Chg, %
Long position overnight fee -0.0192%
Short position overnight fee 0.0110%
Overnight fee time 22:00 (UTC)
Spread 0.50

BTC/USD

38,041.60 Price
+2.540% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Oil - Crude

76.62 Price
+2.000% 1D Chg, %
Long position overnight fee -0.0187%
Short position overnight fee -0.0032%
Overnight fee time 22:00 (UTC)
Spread 0.030

US100

16,014.00 Price
+0.300% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading